Manu Thomas Kalathottukaren

Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants

Rajesh A. Shenoi, Manu Thomas Kalathottukaren, Richard J. Travers et al. · Science Translational Medicine · 2014 · 90 citations

Medicine, Pharmaceutics, Pharmacology +17

Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis

Richard J. Travers, Rajesh A. Shenoi, Manu Thomas Kalathottukaren et al. · Blood · 2014 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Toward Infection-Resistant Surfaces: Achieving High Antimicrobial Peptide Potency by Modulating the Functionality of Polymer Brush and Peptide

Kai Yu, Joey Lo, Yan Mei et al. · ACS Applied Materials & Interfaces · 2015 · 87 citations

Engineering, Bioengineering, Biomedical Engineering +17

Antimicrobial Peptide–Polymer Conjugates with High Activity: Influence of Polymer Molecular Weight and Peptide Sequence on Antimicrobial Activity, Proteolysis, and Biocompatibility

Prashant Kumar, Allen Takayesu, Usama Abbasi et al. · ACS Applied Materials & Interfaces · 2017 · 75 citations

Natural Sciences, Biochemistry, Bioengineering +17

Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors

Manu Thomas Kalathottukaren, A. Louise Creagh, Srinivas Abbina et al. · Blood Advances · 2018 · 64 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10